Cuba: Directors of the Finlay Vaccine Institute held a virtual meeting with specialists from the Pan American and World Health organizations, where they discussed the progress of the Cuban vaccine candidate, Radio Rebelde reports.
The meeting took place at the PAHO / WHO headquarters in Cuba, as Carlos Fidel Martin Rodríguez, director of the National Directorate of International Economic Organizations of the Ministry of Foreign Trade and Foreign Investment, announced on his Twitter account.
SOBERANA 01 has been called the phase 1 and 2 clinical trial that will validate the efficacy of the Cuban vaccine candidate, which began to be applied to a group of volunteers on August 24 of this year.
